Sign In  |  Register  |  About Los Altos  |  Contact Us

Los Altos, CA
September 01, 2020 1:26pm
7-Day Forecast | Traffic

  • Search Hotels in Los Altos

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY: ABT )

116.12 +0.50 (+0.43%)
Official Closing Price Updated: 7:00 PM EDT, Oct 11, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Abbott Laboratories

< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
33 34 Next >
Analyst Ratings for Abbott Laboratories
Within the last quarter, Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings: 
Via Benzinga
Where Abbott Laboratories Stands With Analysts
Within the last quarter, Abbott Laboratories (NYSE:ABT) has observed the following analyst ratings: 
Via Benzinga
Analyzing Abbott Laboratories's Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has risen 23.68% since its last report. The company recently reported that it has 16.03 million shares sold short, which is 0.94% of all regular... 
Via Benzinga
3 Diabetes Care Stocks That Could Help Set You Up for Life
These companies are three of the leading manufacturers of continuous glucose monitoring systems. 
Via The Motley Fool
2 Top Healthcare Stocks to Buy Right Now
Healthcare is about as sticky of a business model as you'll find. 
Via The Motley Fool
3 Great Dividend Stocks to Buy in October
Their dividends should be much bigger in the future. 
Via The Motley Fool
FDA Approves Abbott's New Spinal Cord Stimulation Device For Pain
Via Benzinga
Why DexCom Stock Popped on Friday, Even as the Market Crumbled
The medical device maker could benefit from a pending decision by Medicare that could be a game changer. 
Via The Motley Fool
Abbott Laboratories Whale Trades For October 06
A whale with a lot of money to spend has taken a noticeably bullish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories (NYSE:ABT) we detected 10 strange trades. 
Via Benzinga
Best Stocks 2022: What’s Not to Like About AbbVie (ABBV) Stock?
ABBV stock has rightly earned its place among the Best Stocks for 2022. This Dividend King is outperforming the S&P 500. 
Via InvestorPlace
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.74% on an annualized basis producing an average annual return of 11.68%. Currently, Abbott Laboratories has a... 
Via Benzinga
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
Via Benzinga
7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’
Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over. 
Via InvestorPlace
Awakn And Catalent's Partnership Could Provide Hope For People Suffering From Addiction
Since 2020, Awakn Life Sciences Corp. (OTCQB: AWKNF) reports that it has been researching, developing and commercializing therapeu 
Via Benzinga
COVID-19 Complacency Pushes Identification Of New Variants To Back Seat, WHO Warns
The World Health Organization (WHO) warned that it struggles to identify and 
Via Benzinga
Looking Into Abbott Laboratories's Recent Short Interest
Abbott Laboratories's (NYSE:ABT) short percent of float has fallen 7.32% since its last report. The company recently reported that it has 12.94 million shares sold short, which is 0.76% of all regular... 
Via Benzinga
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years
Abbott Laboratories (NYSE:ABT) has outperformed the market over the past 10 years by 1.57% on an annualized basis producing an average annual return of 11.72%. Currently, Abbott Laboratories has a... 
Via Benzinga
FDA Concludes Oversight Shortcomings After Infant Formula Internal Review
The FDA concluded an internal review of agency actions related to the U.S. infant formula supply. 
Via Benzinga
5 Dividend Growth Stocks That Have Totally Collapsed
Today, I want to tell you about 5 dividend growth stocks that are down more than 20% from their recent highs. 
Via Talk Markets
Weekend Stock Spotlight: Netflix, Meta, NVIDIA, Disney And The Battle For The Stable Coin Market
Benzinga reviews this weekend's top stories covered by leading media outlets, here are the articles investors need to read. 
Via Benzinga
7 Top-Rated Biotech Stocks to Buy for Q4
A new White House program makes these seven names some outstanding biotech stocks to buy for the fourth quarter. 
Via InvestorPlace
Dividend Income Update August 2022
It’s dividend income update time. One of my favorite times of the month as I get to review my previous month of passive income received from my dividend income portfolio. 
Via Talk Markets
Top Financial Stories Friday, September 09: Elon Musk Hints At Potential Apple-SpaceX Partnership, GM's EV For Cost Conscious Buyers, Google Under DOJ Scanner For Search-Engine Dominance And More...
Bloomberg When The Bank Error Is Not In Your Favor: Pay Back $500 Million 
Via Benzinga
FDA Warns of Clip Lock Malfunctions With Abbott's MitraClip Heart Valve Devices
The FDA alerted healthcare providers about the potential for clip lock malfunctions with Abbott Laboratories (NYSE: ABT) MitraClip's delivery system to stop heart valve leakage. 
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity... 
Via Benzinga
No More Free COVID-19 At-Home Tests, Federal Government Says
CNBC reported that the federal government is set to suspend its offer of free at-home COVID-19 tests by Friday, September 2, without congressional au 
Via Benzinga
Growing Adoption Of This Company's Technologies Could Reportedly Prevent Alcohol Abuse in Workplaces
SOBR Safe Inc. (NASDAQ: SOBR) reports helping to fight a growing alcohol addiction in the workplace. 
Via Benzinga
There Could Be More Hope For Alcohol Addicts As This Company Enters U.S. Addiction Treatment And Relapse Prevention Market
For people suffering from any type of addiction, getting the best medical care can make a significant difference in their journey to recovery. In the case of alcohol abuse, for example, the talk about... 
Via Benzinga
With Alcohol Abuse On The Rise, Could This Company's Virtual and Remote Rehabilitation Program Help?
For centuries, the consumption of alcoholic beverages has played an important social role in many cultures. While it can fuel excitement during personal moments or at gatherings, excessive use can be... 
Via Benzinga
MedTech Giant Abbott To Inject Over €400M In Ireland To Expand Production Of Glucose Monitoring Tech
Via Benzinga
< Previous 1 2
...
18 19 20 21 22 23 24 25 26
...
33 34 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 LosAltos.com & California Media Partners, LLC. All rights reserved.